Evidence map›Paper›PMID 22460652›Full record

ArticleKidney international2012

A possible mechanism of renal cell death after ischemia/reperfusion.

Peter M Price, Rawad Hodeify

Abstract readComment
In one paragraph

Article in Kidney international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cell Death in the Kidney.International journal of molecular sciences · 2019
    Review
  7. Article
  8. Article
  9. TRPC6 May Protect Renal Ischemia-Reperfusion Injury Through Inhibiting Necroptosis of Renal Tubular Epithelial Cells.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  10. Article
  11. Ischemia as a factor affecting innate immune responses in kidney transplantation.Current opinion in nephrology and hypertension · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Peter M PriceDepartment of Internal Medicine and Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. PricePeterM@uams.edu
Rawad Hodeify

Funding

CYCLIN DEPENDENT KINASE INHIBITOR IN ACUTE RENAL FAILURER01DK054471 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI PRICE, PETER M. · 1998 to 2013
$2.3M
NIDDK NIH HHS R01 DK054471
6 · The paper itself

Abstract

Linkermann et al. provide the first evidence for a possible biochemical mechanism of necrotic kidney cell death associated with renal ischemia/reperfusion-induced acute kidney injury. The mechanisms of several pathways resulting in programmed necrosis were recently elucidated and rely on receptor-interacting protein kinases 1 and 3. Using an inhibitor of one of these kinases, Linkermann et al. were able to ameliorate functional and morphologic kidney damage after ischemia/reperfusion.

Indexed as

AnimalsHumansKidneyMaleReceptor-Interacting Protein Serine-Threonine KinasesReperfusion InjuryReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouse

Identifiers

PMID22460652
PMCPMC3324283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.